NasdaqGS - Nasdaq Real Time Price USD
Xeris Biopharma Holdings, Inc. (XERS)
4.8400
-0.0400
(-0.82%)
As of 1:44:42 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-26,709
-36,981
-47,023
-102,891
-95,535
Investing Cash Flow
24,520
4,883
-6,004
34,461
97,964
Financing Cash Flow
-2,163
36,168
-1,613
127,473
27,247
End Cash Position
62,563
75,744
71,674
126,314
67,271
Interest Paid Supplemental Data
25,447
26,948
27,686
10,859
7,294
Capital Expenditure
-717
-868
-2,263
-524
-1,085
Issuance of Capital Stock
--
0
0
30,000
27,000
Issuance of Debt
0
50,000
0
146,214
0
Repayment of Debt
0
-11,831
0
-44,233
0
Repurchase of Capital Stock
-8,298
-3,734
-1,009
-468
-534
Free Cash Flow
-27,426
-37,849
-49,286
-103,415
-96,620
12/31/2021 - 6/21/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MREO Mereo BioPharma Group plc
2.2350
-0.22%
RCKT Rocket Pharmaceuticals, Inc.
6.44
-0.88%
ADMA ADMA Biologics, Inc.
19.78
+0.43%
ABEO Abeona Therapeutics Inc.
6.17
+1.15%
ANAB AnaptysBio, Inc.
20.27
+0.25%
SGMO Sangamo Therapeutics, Inc.
0.4882
+3.87%
HRTX Heron Therapeutics, Inc.
1.9250
-2.28%
NKTR Nektar Therapeutics
0.6726
-1.81%
HUMA Humacyte, Inc.
2.2050
-1.57%
FOLD Amicus Therapeutics, Inc.
6.43
-0.08%